home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  June 21, 2018
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 556 active entries

Chengdu Likai Chiral Tech Co., Ltd.

Room 710, Kefenyuan Complex, 9#, Section 4,Renminn

Phone: +86-28-85233564
Fax: +86-28-85259387

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


Our company is a high-tech enterprise engaged in technology development and manufacture of chiral reagents, chiral organic chemical intermediate products, chiral medical primary products and specializes in chiral technology industrialization. Supported by the National Engineering Research Center for Chiral Drugs, the company has strong research and development capabilities in the field of chiral products to meet various market demands and has successfully commercialized a number of chiral products, including optical active tartaric derivatives, chiral diamine, chiral aminoalcohols. The company is actively pursuing national and international collaboration to expand the chiral technology to new applications.

Our main products: Di-m-toluoyl-L-tartaric acid, Di-m-toluoyl-D-tartaric acid, Di-o-toluoyl-D-tartaric acid, Di-o-toluoyl-L-tartaric acid, (1S,2S)-(+)-N-p-Tosyl-1,2-diphenylethylenediamine 167316-27-0, (1R,2R)-(-)-N-p-Tosyl-1,2-diphenylethylenediamine 144222-34-4, (R)-1,2,3,4-tetrahedro-naphthoic acid 23357-47-3, (S)-1,2,3,4-tetrahedro-naphthoic acid 85977-52-2, 2, 4-Dichloro-α-phenethylamine, (1R,2S)-(-)-2-Amino-1,2-diphenylethanol 23190-16-1, (1S,2R)-(+)-2-Amino-1,2-diphenylethanol 23364-44-5, (S)-(-)-2-Carboxy-tetrahydrofuroic-acid 87392-07-2, (R)-(+)-2-Carboxy-tetrahydrofuroic-acid 87392-05-0,(1S,2S)-(-)-1,2-Diphenylethylenediamine 29841-69-8, (1R,2R)-(+)-1,2-Diphenylethylenediamine 35132-20-8, Dibenzoyl-(-)-P-methoxy-L-tartaric acid 50583-51-2, Dibenzoyl-(+)-P-methoxy-D-tartaric acid 191605-10-4, Dibenzoyl-L-tartaric acid monohydrate 62708-56-9, Dibenzoyl-D-tartaric acid monohydrate 80822-15-7, Di-p-toluoyl-L-tartaric acid monohydrate, Di-p-toluoyl-D-tartaric acid monohydrate 71607-32-4, Diisoprropyl-L-tartrate 2217-15-4, Diisoprropyl-D-tartrate 62961-64-2, Dibenzoyl-L-tartaric acid 2743-38-6, Dibenzoyl-D-tartaric acid 17026-42-5, Di-p-toluoyl-L-tartaric acid 32634-66-5, Di-p-toluoyl-D-tartaric acid 32634-68-7, Dimethyl-L-tartrate 608-68-4, Dimethyl-D-tartrate 13171-64-7, Diethyl-L-tartrate 87-91-2, Diethyl-D-tartrate 13811-71-7.

Selected Categories:
Product Company   Service Company
- General
- General

Last update of this entry: November 12, 2008

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.